PASK and metabolic dysfunction-associated steatotic liver disease: Hence, our finding suggest for the first time that PASK-mediated inhibition of lipid accumulation may be a potential mechanism of nuciferine in alleviating NAFLD probably by regulating the expression of PASK, AMPK, SREBP-1c, and relevant targets genes (Figure 6).